“We have emails, text messages, telephone records, and former company insiders that we believe will prove a multi-year conspiracy to fix prices and divide market share for huge numbers of ...

doubling down on its mission to make high-quality generic medication more affordable and accessible to patients in the U.S. The company's new three-story plant, a $250 million investment that will ...

“We have emails, text messages, telephone records, and former company insiders that we believe will prove a multi-year conspiracy to fix prices and divide market share for huge numbers of ...